Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sameerpannag Rasa is a traditional Ayurvedic herbomineral formulation (Kupipakwa Rasayana) primarily composed of mercury, sulfur, and arsenic compounds, including arsenic trioxide, realgar, and orpiment. It is traditionally used to treat Vata-related disorders, such as rheumatoid arthritis, bronchial asthma (Tamaka Shwasa), and chronic respiratory conditions. Research suggests it may possess neuroprotective properties in ischemic stroke by attenuating neuroinflammatory responses and suppressing inflammatory gene expression. Due to its heavy metal content, it is typically administered in minute doses under strict medical supervision and is prepared using traditional purification (Shodhana) processes to mitigate toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sameerpannag Rasa.